1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3380)
  2. Meeting Abstract (1548)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5517)
  2. GSK Faculty (5319)
  3. Sloan Kettering Institute Faculty (3448)
  4. Tow Center for Developmental Oncology (TCDO) (2542)
  5. Department of Medicine (2440)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1825)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (432)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (150)
  3. 2023 (248)
  4. 2022 (308)
  5. 2021 (289)
  6. 2020 (331)

More Years

Publications
  1. Blood (632)
  2. Cancer Research (190)
  3. Journal of Clinical Oncology (170)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (662)
  2. Nature Publishing Group (527)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (369)
  5. Cell Press (355)
  6. Springer (202)

More Publishers

Results (5517)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • STK11 and KEAP1 co-mutation cooperatively promotes rapid tumor growth in lung adenocarcinoma
    Meeting Abstract

    Wohlhieter, C. A.; Richards, A. L.; Poirier, J. T.; Uddin, F.; Hulton, C.; De Stanchina, E.; Papagiannakopoulos, T.; Sen, T.; Rudin, C. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A primary mouse model of AML as a new way to screen novel therapeutics and treatment combinations
    Meeting Abstract

    Johnson, M. L.; Elgamal, O. A.; Harrington, B.; Mustonen, A.; Lehman, A.; Bennett, C.; Dzwigalski, K. R.; Hill, K. L.; Phelps, M. A.; Truxall, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Renal tubule-targeted supportive care nanotherapy for cisplatin-induced acute kidney injury
    Meeting Abstract

    Heller, D. A.; Jaimes, E.; Williams, R.; Shah, J.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Pancreatic cancer prognosis is predicted by chromatin accessibility microarray
    Meeting Abstract

    Dhara, S.; Chhangawala, S.; Chintalapudi, H.; Massa, A. L.; Aveson, V.; Askan, G.; Zhang, L.; Nicolle, R.; Makohon-Moore, A. P.; Sinha, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The cBioPortal for Cancer Genomics
    Meeting Abstract

    Gao, J.; Mazor, T.; Abeshouse, A.; de Bruijn, I.; Gross, B.; Kalletla, K.; Kumari, P.; Kundra, R.; Li, X.; Lindsay, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Drug-loaded porphyrin nanoparticles as a platform for targeted and photodynamic combination therapy
    Meeting Abstract

    Cheung, J. M.; Baker, H.; Li, D.; Stor, D.; Heller, D. A.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Cell state diversity promotes metastasis through heterotypic cluster formation in melanoma
    Meeting Abstract

    Campbell, N. R.; Zhang, M.; Baron, M.; Heilmann, S.; Deforet, M.; Ferretti, L.; Huang, T. H.; Levesque, M. P.; Yanai, I.; Xavier, J. B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Preclinical characterization of PRT543, a potent and selective inhibitor of protein arginine methyltransferase 5 (PRMT5), with broad antitumor activity in in vitro and in vivo models
    Meeting Abstract

    Bhagwat, N.; Zhang, Y.; Lin, H.; Wang, M.; Rominger, D.; Emm, T.; Chugani-Mahtani, D.; Angelis, D.; Shetty, R.; Leal, R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save